103 related articles for article (PubMed ID: 22389297)
1. FOXP3 expression in esophageal cancer cells is associated with poor prognosis in esophageal cancer.
Wang G; Liu G; Liu Y; Li X; Su Z
Hepatogastroenterology; 2012 Oct; 59(119):2186-91. PubMed ID: 22389297
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of her-2 associated with the progression of esophageal cancer patients.
Wang G; Zhang W; Jiang W; Luan L
Hepatogastroenterology; 2013; 60(128):1972-8. PubMed ID: 24719937
[TBL] [Abstract][Full Text] [Related]
3. VEGF-C: an indicator of lymph node metastasis for patients that underwent esophagectomy.
Wang X
Hepatogastroenterology; 2012 Oct; 59(119):2027-31. PubMed ID: 22626857
[TBL] [Abstract][Full Text] [Related]
4. Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy.
Ladoire S; Arnould L; Mignot G; Coudert B; Rébé C; Chalmin F; Vincent J; Bruchard M; Chauffert B; Martin F; Fumoleau P; Ghiringhelli F
Breast Cancer Res Treat; 2011 Jan; 125(1):65-72. PubMed ID: 20229175
[TBL] [Abstract][Full Text] [Related]
5. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.
Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY
J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008
[TBL] [Abstract][Full Text] [Related]
6. Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma.
Luo KJ; Wen J; Xie X; Fu JH; Luo RZ; Wu QL; Hu Y
Ann Thorac Surg; 2012 May; 93(5):1682-8. PubMed ID: 22480390
[TBL] [Abstract][Full Text] [Related]
7. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma.
Glickman JN; Torres C; Wang HH; Turner JR; Shahsafaei A; Richards WG; Sugarbaker DJ; Odze RD
Cancer; 1999 Feb; 85(4):769-78. PubMed ID: 10091753
[TBL] [Abstract][Full Text] [Related]
9. [Influence of number of removed lymph nodes on the TNM staging and survival in advanced esophageal carcinoma].
Chen LQ; Hu CY; Zhang HL; He M; Meng XL; Ping YM
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):604-8. PubMed ID: 18210881
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma.
Cao X; Li Y; Luo RZ; He LR; Yang J; Zeng MS; Wen ZS
Ann Thorac Surg; 2012 May; 93(5):1674-80. PubMed ID: 22429674
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic analysis of clinicopathological factors in patients after radical resection of esophageal carcinoma].
Zhu SC; Song CL; Shen WB; Su JW; Li J; Liu ZK
Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):281-6. PubMed ID: 22781041
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic value of MG7-Ag in patients with surgically resectable esophageal squamous cell carcinoma.
Zhao Y; Jiang Y; Wang R; Zheng X; Wang X; Jin B; Lu Y; Qiao T; Hong L; Fan D
Ann Surg Oncol; 2007 Sep; 14(9):2621-7. PubMed ID: 17570016
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer.
Sharma R; Chattopadhyay TK; Mathur M; Ralhan R
Oncology; 2004; 67(3-4):300-9. PubMed ID: 15557792
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of FOXQ1 oncogene overexpression in human hepatocellular carcinoma.
Wang W; He S; Ji J; Huang J; Zhang S; Zhang Y
Pathol Res Pract; 2013 Jun; 209(6):353-8. PubMed ID: 23623360
[TBL] [Abstract][Full Text] [Related]
15. Investigations on the clinical significance of FOXP3 protein expression in cervical oesophageal cancer and the number of FOXP3+ tumour-infiltrating lymphocytes.
Xia M; Zhao MQ; Wu K; Lin XY; Liu Y; Qin YJ
J Int Med Res; 2013 Aug; 41(4):1002-8. PubMed ID: 23760912
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma.
Li SH; Huang EY; Lu HI; Huang WT; Yen CC; Huang WC; Chen CH
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1352-9, 1359.e1. PubMed ID: 22841170
[TBL] [Abstract][Full Text] [Related]
17. [Survival analysis of patients with stage II squamous cell carcinoma of the thoracic esophagus after esophagectomy].
Zhang DK; Su XD; Lin P
Ai Zheng; 2008 Feb; 27(2):113-8. PubMed ID: 18279605
[TBL] [Abstract][Full Text] [Related]
18. MTA1: a prognosis indicator of postoperative patients with esophageal carcinoma.
Song L; Wang Z; Liu X
Thorac Cardiovasc Surg; 2013 Sep; 61(6):479-85. PubMed ID: 22547301
[TBL] [Abstract][Full Text] [Related]
19. CCR7 and VEGF-C: molecular indicator of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
Song Y; Wang Z; Liu X; Jiang W; Shi M
Ann Surg Oncol; 2012 Oct; 19(11):3606-12. PubMed ID: 22644515
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]